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Functional Studies of the Recombinant Subunits of a Cytolethal Distending
Holotoxin
Abstract
Cytolethal distending toxin (CDT) is a multicomponent bacterial holotoxin that targets most eukarytotic
cells causing distension and cell cycle arrest. A number of diverse pathogenic bacterial species
associated with diarrhoea, chancroid, chronic hepatitis and periodontal disease produce a CDT. Synthesis
of the holotoxin is directed by the expression of three genes, cdtA, cdtB and cdtC. Although the product of
the CdtB gene was previously identified as a type I deoxyribonuclease, the functions of the cdtA and cdtC
products have not been characterized. Using the periodontal pathogen, Actinobacillus
actinomycetemcomitans, we demonstrate that the recombinant product of the CdtA gene binds to the
surface of Chinese hamster ovary (CHO) cells. This protein did not induce distension or cytotoxicity when
introduced into the cytosol using a lipid-based protein delivery system. Recombinant CdtB and CdtC
proteins failed to bind to CHO cells. However, the delivery of either CdtB or CdtC into the cytosol resulted
in the characteristic pattern of distension followed by cell death. Based on these results, it appears that
the CdtA protein subunit alone is responsible for anchoring the holotoxin to the cell surface. The CdtC
subunit, in concert with CdtB, contributes to the cytotoxic activities of the holotoxin. The specific
mechanism of CdtC cytotoxicity is currently unknown.

Disciplines
Dentistry

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/dental_papers/145

NIH Public Access
Author Manuscript
Cell Microbiol. Author manuscript; available in PMC 2006 April 10.

NIH-PA Author Manuscript

Published in final edited form as:
Cell Microbiol. 2002 April ; 4(4): 245–255.

Functional studies of the recombinant subunits of a cytolethal
distending holotoxin
Xiangqun Mao and Joseph M. DiRienzo*
Department of Microbiology, School of Dental Medicine, University of Pennsylvania, 4001 Spruce
Street, Philadelphia, Pennsylvania 19104-6002, USA.

Summary
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Cytolethal distending toxin (CDT) is a multicomponent bacterial holotoxin that targets most
eukarytotic cells causing distension and cell cycle arrest. A number of diverse pathogenic bacterial
species associated with diarrhoea, chancroid, chronic hepatitis and periodontal disease produce a
CDT. Synthesis of the holotoxin is directed by the expression of three genes, cdtA, cdtB and cdtC.
Although the product of the CdtB gene was previously identified as a type I deoxyribonuclease, the
functions of the cdtA and cdtC products have not been characterized. Using the periodontal pathogen,
Actinobacillus actinomycetemcomitans, we demonstrate that the recombinant product of the CdtA
gene binds to the surface of Chinese hamster ovary (CHO) cells. This protein did not induce distension
or cytotoxicity when introduced into the cytosol using a lipid-based protein delivery system.
Recombinant CdtB and CdtC proteins failed to bind to CHO cells. However, the delivery of either
CdtB or CdtC into the cytosol resulted in the characteristic pattern of distension followed by cell
death. Based on these results, it appears that the CdtA protein subunit alone is responsible for
anchoring the holotoxin to the cell surface. The CdtC subunit, in concert with CdtB, contributes to
the cytotoxic activities of the holotoxin. The specific mechanism of CdtC cytotoxicity is currently
unknown.

Introduction
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The facultative Gram-negative bacterium Actinobacillus actinomycetemcomitans has served
as a model system for studying the contribution of pathogenic bacterial species and their
products to the initiation and progression of oral infectious diseases. This bacterium has a strong
historical association with localized aggressive periodontitis (LAP; formerly localized juvenile
periodontitis) and, to some extent, adult forms of periodontitis. A novel property of specific
strains of A. actinomycetemcomitans is the expression of several complex multigene toxin
systems not found in other recognized periodontal pathogens. These multigene toxin systems
include a leucotoxin (for a review, see Lally et al., 1999) and the more recently identified
cytolethal distending toxin (CDT) (Sugai et al., 1998; Mayer et al., 1999; Shenker et al.,
1999).
Although the genetic organization of the leucotoxin locus and the biological activities of its
associated gene products have been well studied, the functions and interactions of the CDT
genes and gene products are just beginning to be deciphered. The cdt locus in A.
actinomycetemcomitans Y4 is composed of three genes (cdtA–C), which appear to form a
polycistronic operon (Mayer et al., 1999; Shenker et al., 2000). The gene products for the
cdtA, cdtB and cdtC genes are ≈ 27, 30 and 20 kDa, respectively, and it is apparent that
expression of all three genes is required for cytotoxicity in vivo (Mayer et al., 1999). The
deduced amino acid sequences derived from the three cdt genes are ≈ 25–50% similar (Mayer
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et al., 1999) to those from Escherichia coli (Pickett et al., 1994; Scott and Kaper, 1994), Shigella
dysenteriae (Okuda et al., 1995) and Campylobacter jejuni (Pickett et al., 1996) and > 90%
similar to those from Haemophilus ducreyi (Cope et al., 1997).
The CDT from E. coli, C. jejuni, H. ducreyi, A. actinomycetemcomitans and, more recently,
Helicobacter hepaticus irreversibly block the cell cycle at the G2 phase of growth in a wide
range of host cells (Comayras et al., 1997; Pérès et al., 1997; Sugai et al., 1998; Whitehouse
et al., 1998; Cortes-Bratti et al., 1999; Shenker et al., 1999; Young et al., 2000). The inhibition
is relatively rapid, usually occurring within 48–72 h of exposure of the cells to bacterial extracts.
The cells continue to grow, as protein synthesis is not disrupted, but cannot divide, thus
producing the characteristic enlarged or distended cell morphology. It has been proposed that
the CDT may inhibit the dephosphorylation of Cdc2 protein kinase by Cdc25 (Comayras et
al., 1997; Whitehouse et al., 1998; Cortes-Bratti et al., 1999; 2001; Shenker et al., 1999). This
dephosphorylation step is believed to trigger mitosis in normal cells by activation of a Cdc2–
cyclin-B1 complex (Pickett and Whitehouse, 1999; Elwell and Dreyfus, 2000).
Lara-Tejero and Galán (2001) used purified recombinant Cdt proteins, from C. jejuni, in
glutathione-S-transferase (GST) pull-down, co-immunoprecipitation and gel filtration assays,
the results of which supported the possibility that CdtA, CdtB and CdtC combine to form a
tripartite complex to create an active holotoxin.
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The products of the cdtB genes of E. coli (Elwell and Dreyfus, 2000) and C. jejuni (Lara-Tejero
and Galán, 2000) exhibit a type I deoxyribonuclease (DNase I)-like activity that disrupts the
chromatin structure of the cell. It is now clear that CdtB belongs to a large enzyme superfamily
composed of sphingomyelinases (nSMases), exonucleases, endonucleases and inositol
polyphosphate 5-phosphatases (Hofmann et al., 2000). CdtB resides in a subfamily most
closely related to mammalian DNase I-type secreted nucleases.
The biological functions of the cdtA and cdtC genes have not yet been identified. Hofman et
al. (2000) proposed a similarity between CdtA and the B chain of the plant toxin ricin based
on an undisclosed computer alignment algorithm. Ricin is composed of an A subunit that
inactivates 80S ribosomes once carried into the cell and a B subunit that attaches to
carbohydrate receptors on the cell surface to stimulate uptake of the toxin (Rutenber et al.,
1987). The B subunit is a 31 400 kDa polypeptide that binds two galactosides non-cooperatively. This theoretical functional similarity between ricin-like proteins and CdtA has not
been substantiated experimentally. No information is available, from either computer or
empirical analyses, for elucidating the specific function of CdtC.
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In the present study, we report the use of recombinant Cdt proteins, originating from A.
actinomycetemcomitans, to examine the biological activities of the individual subunits of the
holotoxin. The activities of CdtA and CdtC were assessed using immunofluorescence detection
techniques, a protein delivery system and cytotoxicity assays in a Chinese hamster ovary
(CHO) cell model system. The recombinant CdtA protein was the only one of the three Cdt
proteins that bound to the cells under the conditions used. Both recombinant CdtB and CdtC
proteins induced CHO cell distension and cell death when artificially delivered, independently,
into actively growing cells. These data are the first to demonstrate that CdtC, completely free
from contamination with CdtA and CdtB, has cytotoxic effects.

Results
Cloning, expression and purification of cdtA, cdtB and cdtC
As the level of expression of the cdt genes in A. actinomycetemcomitans precluded the isolation
of significant quantities of the gene products for functional studies, the three cdt genes were
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cloned independently, and in several combinations, in E. coli. Descriptions of the expression
clones and their phenotypes relative to the known activities of the CDT are provided in Table
1.
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The expression and isolation of the individual recombinant cdt genes is shown in Fig. 1. Totalcell lysates from the clones were examined on SDS–PAGE and stained with Coomassie
brilliant blue (CBB). E. coli BL21(DE3) containing pET15bcdtA, pET15bcdtB and
pET15bcdtC produced significantly elevated quantities of His6-tagged CdtA, CdtB and CdtC,
respectively, relative to the amounts of the native proteins that could be detected in A.
actinomycetemcomitans. Even though whole-cell (sonic) extracts of A.
actinomycetemcomitans contained cytotoxic activity (Mayer et al., 1999), the gene products
were undetectable by staining in SDS–PAGE. The His6-tagged proteins were recovered in
significant quantities by affinity chromatography after induction of the bacterial genes with
IPTG and solubilization of released inclusion bodies with urea. The presence of the His6-tag
provided a convenient and specific method for detecting the recombinant proteins. As shown
in Fig. 2, the recombinant His6-tagged CdtA–C proteins were readily detected on Western blots
using an anti-His monoclonal antibody. This antibody was also used to confirm that CdtA made
by clones E. coli BL21(DE3) (pET15bcdt) and E. coli BL21(DE3) (pET15bcdtAB) and CdtB
made by E. coli BL21(DE3) (pET15bcdtBC) contained the His6 tag (data not shown). No
immunopositive bands were detected with the anti-His monoclonal antibody on Western blots
using sonic extract from E. coli BL21(DE3) (pET15b).
The distension and growth arrest of CHO cells in tissue culture was observed only with sonic
lysates and spent culture medium from the recombinant clone [E. coli BL21(DE3)
(pET15bcdt)] that expressed all three cdt genes. These results were expected, as expression of
all three genes is required to observe cytotoxicity in the cell assays. Sonic extracts and spent
culture medium from clones expressing the cdtA/cdtB and cdtB/cdtC genes, as single
transcriptional units, were devoid of toxic activity.
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Whole-cell lysates and spent cell medium from recombinant clones E. coli BL21(DE3)
(pET15bcdt), E. coli BL21(DE3) (pET15bcdtB) and E. coli BL21(DE3) (pET15bcdtAB)
expressed DNase I-like activity when assayed with supercoiled plasmid DNA as the substrate.
In some experiments, limited, but detectable, background DNA nicking activity was evident
as a result of undefined nuclease activity in lysates from the E. coli host. Various host
modification- and restriction-defective strains of E. coli, including E. coli JM109 and E. coli
HB101, were tested to try to minimize this extraneous nuclease background. This approach
was unsuccessful. However, the DNase activity of purified His6-tagged CdtB from E. coli
BL21(DE3) (pET15bcdtB) was free from this intrinsic background and readily measured by a
conversion of supercoiled (S) form plasmid DNA to the relaxed (R) form (Fig. 3). Furthermore,
the purified His6-tagged CdtB was biologically active in spite of having a 27-amino-acid
extension (MGSSHHHHHHSSGLVPRGSHMLEDPVY) at the amino-terminal end of the
protein. Neither His6-tagged CdtA nor His6-tagged CdtC exhibited nuclease nicking activity
in the mobility shift assay.
Reconstitution of biologically active recombinant holotoxin
Various concentrations of purified His6-tagged CdtA, His6-tagged CdtB and His6-tagged CdtC
were added to CHO cell cultures alone and in combination to determine which proteins were
required to establish a toxic phenotype. These experiments were also performed to determine
whether a biologically active holotoxin could be assembled in vitro from the recombinant
proteins. Each of the purified His6-tagged proteins alone (3–30 mg of protein per 240 cells)
had no effect on the morphology and growth of the CHO cells after 6–7 days in culture (Fig.
4). Likewise, preincubated mixtures of CdtA/CdtB (15 μg/1.5 μg of protein per 240 cells) and
CdtB/CdtC (1.5 μg/15 μg of protein per 240 cells) did not affect the growth or survival of CHO
Cell Microbiol. Author manuscript; available in PMC 2006 April 10.
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cells. Mixtures of all three recombinant proteins, in various ratios, caused a reduction in the
colony-forming units (cfu) of the CHO cell cultures. A ratio of 30 μg of His6-tagged CdtA:3
μg of His6-tagged CdtB:30 μg of His6-tagged CdtC/240 cells reduced the survival of the CHO
cells in culture to 0 cfu.
Functional studies of the CdtA and CdtC proteins
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A conserved domain (CD) database search, using an RPS (reverse position specific)-BLAST
algorithm (http://www.ncbi.nlm.nih.gov/), revealed that a portion of the deduced amino acid
sequence of the recombinant A. actinomycetemcomitans cdtA gene, representing amino acids
123–211, has a match to the amino-terminal end (residues 1–83) of the B chain of ricin. The
CD alignment length was 125 residues with 66.4% aligned. The score was 33.5 bits with an
E-value of 0.001. These findings support the possibility that the CdtA protein works by a lectinlike interaction to bind the holotoxin to the eukaryotic cell surface (Lara-Tejero and Galán,
2001). To test this hypothesis, His6-tagged CdtA protein, as well as His6-tagged CdtB and
His6-tagged CdtC as controls, were incubated with CHO cells, and immunofluorescence was
used to document binding to the cell surface. As shown in Fig. 5A, the His6-tagged CdtAtreated cells contained bound fluorescent-labelled antibody with localized regions of intense
fluorescence. Neither His6-tagged CdtB nor His6-tagged CdtC proteins were detected on the
CHO cells (Fig. 5B and C respectively). Fluorescence of low intensity was observed when the
CHO cells were incubated with a preincubated mixture of all three recombinant proteins (Fig.
5D). As in the case of recombinant CdtB, biological function was observed in spite of the
amino-terminal modification (MGSSHHHHHHSSGLVPRGSHMLERGT) of His6-tagged
CdtA.
To determine the contribution and extent of the individual His6-tagged Cdt proteins to the
cytotoxic effects of the holotoxin, a lipid-based protein delivery system (BioPorter protein
delivery reagent; Gene Therapy Systems) was used to put each protein, and mixtures of
proteins, inside the cells. Increasing concentrations, ranging from 7 to 1000 ng, of His6-tagged
CdtA, His6-tagged CdtB and His6-tagged CdtC were introduced into CHO cells in tissue
culture, and the effects of the proteins on cell survival were observed (Fig. 6A). Up to 1 mg of
His6-tagged CdtA/5 × 103 CHO cells had no effect on growth or cell viability. A decrease in
cell viability was observed with 250 ng of His6-tagged CdtB/5 × 103 cells, which continued in
a dose-dependent fashion with up to 1 μg of the recombinant protein. A similar reduction in
cell viability was obtained with His6-tagged CdtC. A decrease in cell number was observed
with as little as 125 ng of protein/5 × 103 CHO cells. His6-tagged CdtC contained the extra
sequence, MGSSHHHHHHSSGLVPRGSHMLEDPNT, at the amino-terminal end of the
protein.
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The recombinant Cdt proteins were also introduced into the CHO cells in mixtures containing
pairs of the proteins as well as all three proteins (Fig. 6B). No significant reduction in cell
survival was observed when the individual proteins, without the BioPorter reagent, were
incubated with the CHO cells in culture. A slight reduction in viability was apparent when a
mixture of all three proteins, in the absence of the BioPorter reagent, was added to cell cultures.
The effect was not as dramatic as that observed in the reconstitution experiment shown in Fig.
4, because significantly smaller amounts of protein (170 ng of each His6-tagged protein) and
larger numbers of cells (5 × 103 cells) were used in the BioPorter experiments. There did not
seem to be a significant reduction in viability when up to 500 ng of His6-tagged CdtA was
introduced into the cells using the delivery system. However, the uptake of 170–500 ng of
recombinant His6-tagged CdtB and His6-tagged CdtC alone, and in combination with the other
proteins, resulted in a dramatic effect on cell survival. There appeared to be an additive
detrimental effect on cell survival when His6-tagged CdtB and His6-tagged CdtC were
delivered together into the cytosol.
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CDT is a complex holotoxin made by a number of taxonomically distinct Gram-negative
bacterial species including E. coli (Johnson and Lior, 1987a; Scott and Kaper, 1994), Shigella
dysenteriae (Johnson and Lior, 1987b; Okuda et al., 1995; Okuda et al., 1997), C. jejuni
(Johnson and Lior, 1988; Pickett et al., 1996), H. ducreyi (Cope et al., 1997), A.
actinomycetemcomitans (Sugai et al., 1998; Mayer et al., 1999; Shenker et al., 1999) and H.
hepaticus (Young et al., 2000). All these bacteria can be categorized as pathogenic species in
diarrhoeal disease, chancroid, chronic hepatitis or periodontal disease. In general, the CDT
arrests the growth of most types of eukaryotic cells in vitro (Comayras et al., 1997; Pérès et
al., 1997; Oguchi et al., 1998; Cortes-Bratti et al., 1999; Shenker et al., 1999; Escalas et al.,
2000). A multitude of studies has focused on the cell pathways that are affected by the CDT
to induce cell cycle arrest. However, very little information has been published to date to
establish the functional roles of the individual components of the CDT.
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Those bacterial species that exhibit toxic activity have proved to be recalcitrant to the isolation
and purification of the individual Cdt proteins. One of the major difficulties in Cdt protein
purification from the native bacterial species is a consequence of the synthesis of very small
quantities of highly active gene products. For example, we have found that a TD50, for CHO
cells, was obtained with as little as 400 ng of total soluble protein from A.
actinomycetemcomitans (Mayer et al., 1999). Stringently controlled functional studies are also
hampered by the apparent cross-contamination of individual Cdt protein preparations. To
overcome these obstacles, studies of the composition and organization of the CDT holotoxin
have been performed using recombinant proteins isolated from clones that contain single cdt
genes. Dissecting the biological contributions of the individual holotoxin components is
complicated further by the fact that cells in culture are killed by bacterial lysates or spent culture
medium only when all three cdt genes are expressed (Pickett et al., 1994; Scott and Kaper,
1994; Lewis et al., 2001). No cytotoxic effects were observed when individual recombinant
C. jejuni Cdt proteins were added to cultures of Henle-407 intestinal epithelial cells (LaraTejero and Galán, 2001). However, when the three proteins were mixed and added to cells, a
full complement of cytotoxic activity was detected. In the present study, we were able to
duplicate this finding using purified His6-tagged recombinant Cdt proteins from A.
actinomycetemcomitans and CHO cells. But, unlike the observations reported by several other
groups (Purven et al., 1997; Shenker et al., 1999), the addition of purified recombinant CdtC
or CdtB, respectively, to cell cultures did not result in cellular distension or cytotoxic effects.
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Based on the initial report by Hofmann et al. (2000), it was found, using amino acid sequence
threading, that the region encompassing amino acids 160–220 of the CdtA of C. jejuni is similar
to a lectin fold present in the B chains of ricin and abrin (Lara-Tejero and Galán, 2001; Hassane
et al., 2001). The B chain of ricin binds galactosides and is thought to promote the uptake of
the A chain by endocytosis (Rutenber et al., 1987). Therefore, it was proposed that CdtA,
perhaps in combination with CdtC, may have a similar cell receptor-binding function in the
holotoxin (Lara-Tejero and Galán, 2001). However, no experimental evidence has been
reported to substantiate this possibility. We found a similar relationship between the deduced
amino acid sequence of the recombinant A. actinomycetemcomitans CdtA using an RPS-BLAST
search (Altschul et al., 1997). Binding studies were performed based on the results of this
analysis. His6-tagged CdtA, bound to the surface of CHO cells, was confirmed by
immunofluorescence detection. This appeared to be a specific interaction, as neither His6tagged CdtB nor His6-tagged CdtC was detected on the CHO cells under identical experimental
conditions. Binding of the CDT holotoxin to the cell surface was evident but not conclusive
because of significantly reduced fluorescence intensity compared with that obtained with
His6-tagged CdtA. There are a number of reasons why it was difficult to demonstrate binding
of the holotoxin. For instance, the epitopes for the anti-His monoclonal antibody used to detect
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the protein on the cell surface may be masked in the holotoxin complex but exposed on free
His6-tagged CdtA. Furthermore, binding of the holotoxin may be more transient than that of
the His6-tagged CdtA protein because of the size of the complex and the presumed endocytosis
of CdtB or a CdtB–CdtC complex. Interestingly, the addition of various galactosides and
mannosides to the cell cultures failed to inhibit the binding of His6-tagged CdtA. These
observations suggest that the mechanism of binding may be distinct from that of the B chain
of ricin.
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Several groups have shown recently that CdtB is a mammalian-like DNase I that introduces
chromatin damage within the cell nucleus (Elwell and Dreyfus, 2000; Lara-Tejero and Galán,
2000). Either microinjection (Lara-Tejero and Galán, 2000) or electroporation (Elwell et al.,
2001) of recombinant CdtB alone into cells results in cytotoxicity similar to that observed with
the native holotoxin. We have demonstrated a cytotoxic effect using recombinant His6-tagged
CdtB from A. actinomycetemcomitans (see Fig. 4). Cytotoxic activity was observed in spite of
the fact that the protein contained extra amino acids at the amino-terminus. A commercial
protein delivery system was used to introduce the Cdt proteins into the CHO cells. The proteins
are captured by interaction with a charged lipid carrier, and uptake occurs by fusion with the
plasma membrane or endocytosis. The use of this type of delivery technology may be more
advantageous than those methods used previously because it is considerably simpler, requiring
no specialized equipment, and probably less traumatic to the cells than microinjection or
electroporation.
No effect was observed when the recombinant His6-tagged CdtB alone was simply added to
cell cultures. It was established that the purified His6-tagged CdtB had DNase-like activity in
vitro and was active when cells were treated with a mixture containing all three His6-tagged
Cdt proteins. This is in contrast to the previously reported results in which purified CdtB from
A. actinomycetemcomitans (Shenker et al., 1999) or CdtC from H. ducreyi (Purven et al.,
1997; Akifusa et al., 2001) was sufficient to arrest cells in culture. In our hands, mixtures of
His6-tagged CdtA/His6-tagged CdtB and His6-tagged CdtB/His6-tagged CdtC were also not
sufficient to distend or kill CHO cells as reported by Lara-Tejero and Galán, 2001). It appears
that the presence of small amounts of CdtA is required to promote the internalization of CdtB.

NIH-PA Author Manuscript

The precise role of the CdtC protein in the mechanism of action of the holotoxin is unknown
at the present time. The fluorescence binding experiments did not show any evidence of His6tagged CdtC on the surface of the CHO cells when added either alone or in combination with
His6-tagged CdtA. Therefore, His6-tagged CdtC was examined for the ability to affect the
growth of the CHO cells. The expected result was that CdtC would complement or enhance
the ability of CdtB to reduce the survival of the CHO cells. It was surprising to find that delivery
of purified recombinant His6-tagged CdtC into the CHO cells resulted in cellular distension
and eventual death. The results were similar to those obtained with His6-tagged CdtB, such
that cytotoxicity was observed only when the protein was actively transported into the cytosol.
The activities of internalized His6-tagged CdtB and His6-tagged CdtC appeared to be specific
because no effects were observed when purified His6-tagged CdtA was taken up by the cells,
and neither protein affected the cells when added to cultures in the absence of the delivery
reagent. These data supported the results of antibody inhibition studies indicating that CdtC
contributed to the expression of a toxic phenotype (Cope et al., 1997; Mayer et al., 1999). The
cytotoxic effects of His6-tagged CdtC were distinct from those attributed to His6-tagged CdtB
because the former protein failed to exhibit nuclease activity in vitro. Attempts to locate
His6-tagged CdtB and purified His6-tagged CdtC inside the CHO cells by immunofluorescence
were unsuccessful. Lara-Tejero and Galán (2000) were able to stain CdtB that had been
microinjected into COS-1 cells. One difference between our results and those reported by LaraTejero and Galán (2000) may be explained by the difference in methods used to deliver the
proteins into the cytosol. Considerably smaller amounts of protein were used in the protein

Cell Microbiol. Author manuscript; available in PMC 2006 April 10.

Mao and DiRienzo

Page 7

NIH-PA Author Manuscript

delivery technology relative to those used in microinjection. Experiments are in progress to
devise a protocol to localize the His6-tagged CdtC protein in the CHO cells and to determine
whether pathways, similar to those affected by CdtB, are also triggered by CdtC.
The new findings reported in this study expand the biological model for the CDT by
establishing a binding function for CdtA and a cytotoxic function for CdtC. The most
favourable interpretation of the data is that the CdtA protein works alone to bind the holotoxin
to the cell surface. Both CdtB and CdtC proteins are internalized where the CdtC protein
contributes, in an additive fashion with CdtB, to the cytotoxic effects of the holotoxin.

Experimental procedures
Plasmid construction
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The synthetic oligonucleotide primer pairs shown in Table 1 were used to amplify the various
cdt gene sequences for cloning. The primer sequences were based on the sequence of the cdt
locus in A. actinomycetemcomitans Y4 (GenBank accession no. AF006830). The amplified
products were cloned into pET15b to make the constructs shown in Table 1. Amplified gene
sequences cdtB, cdtC and cdtBC were cloned into the BamHI site of pET15b. Amplified gene
sequences cdtA and cdtAB were cloned into the XhoI–BamHI sites of pET15b. All constructs
were first transformed into E. coli JM109 {endA1 gyrA96 hsdR17(rk− mk−) mcrB+ recA1
relA1 supE44 thi-1 Δ(lac-proAB F′[traD36 proAB lacIqZΔM15])} competent cells (Promega)
for long-term storage and as a stable source of plasmid DNA for restriction endonuclease
mapping and DNA sequencing. Transformants were selected on LB agar containing 75 μg
ml−1 ampicillin. Restriction endonuclease mapping was used to confirm that the DNA
fragments were ligated in the proper orientation. Plasmid DNA was then isolated from each of
the clones and transformed into E. coli BL21(DE3) [F− ompT hsdSB (rB− mB−) gal dcm (DE3)]
competent cells (Novagen) primarily for recombinant protein isolation.
Escherichia coli BL21(DE3) (pET15bcdt) was constructed by digesting plasmid DNA from
E. coli DH5a(pCRAA-14) (Mayer et al., 1999) with XhoII and BamHI. The 2.8 kb XhoII–
BamHI DNA fragment containing the three cdt genes was ligated to the BamHI site of pET15b
and transformed into competent cells of E. coli BL21(DE3).
Isolation of recombinant CdtA, CdtB and CdtC proteins
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Single colonies of E. coli BL-21(DE3) (pET15bcdtA), E. coli BL-21(DE3) (pET15bcdtB) and
E. coli BL-21(DE3) (pET15bcdtC) were inoculated separately into 10 ml of LB medium
containing 50 μg ml−1 ampicillin and incubated overnight at 37°C. The overnight culture was
added to 100 ml of the same medium and grown, with vigorous shaking, at 37°C until late log
phase (OD600 = 0.8–1.0) was reached. IPTG was added to a final concentration of 1 mM, and
the cells were grown for an additional 4–5 h. Expression of target genes was assessed by
analysis of total-cell protein on a 10–20% polyacrylamide Tris-HCl Ready Gel (Bio-Rad
Laboratories). Total-cell protein was obtained by boiling an aliquot of the bacterial culture in
gel loading buffer (2% SDS, 0.05 M Tris-HCl, pH 6.8, 10% glycerol) for 5 min. Molecular
weight standards were from Bio-Rad Laboratories.
Bacteria were harvested by centrifugation at 6000 g for 10 min, washed and suspended in 10
ml of 1× binding buffer (5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9). The
suspension was sonicated for three 30 s bursts on ice. The sonicates were centrifuged at 6000
g for 15 min to collect the inclusion bodies. This procedure was repeated, and the final inclusion
body pellets were suspended in 10 ml of 1× binding buffer containing 6 M urea. After
incubation on ice for 1 h to dissolve the protein completely, the suspension was centrifuged at
12 000 g for 30 min. The supernatant fluid was then passed through a 0.45 micron filter.

Cell Microbiol. Author manuscript; available in PMC 2006 April 10.

Mao and DiRienzo

Page 8

NIH-PA Author Manuscript

The bacterial extracts were applied to a 1.0 ml Ni-IDA (nickel–iminodiacetic acid; Novagen,)
column that had previously been equilibrated in 1× binding buffer containing 6 M urea. The
column was washed with the same buffer, followed by wash buffer I (20 mM Tris-HCl, 0.5 M
NaCl, 20 mM imidazole and 6 M urea) and wash buffer II (20 mM Tris-HCl, 0.5 M NaCl, 50
mM imidazole and 6 M urea). Bound protein was eluted with buffer containing 300 mM
imidazole. The eluted proteins were dialysed against 10 mM Tris-HCl (pH 7.9), 100 mM NaCl,
5 mM MgCl2 to promote refolding. On average, the yield of recombinant His6-tagged CdtA,
His6-tagged CdtB and His6-tagged CdtC was 3, 4 and 3 μg of protein ml−1 bacterial culture
respectively.
Western blot analysis
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Bacteria collected from 1 ml of IPTG-induced culture were mixed with 100 μl of gel loading
buffer and heated in a boiling water bath for 5 min. Samples were applied to a 10–20%
polyacrylamide gel (25 μg of protein per lane). After electrophoresis, protein bands were
transferred to a nitrocellulose membrane. The membrane was blocked with 3% BSA in TBS
buffer (20 mM Tris-HCl, pH 7.6, 0.8% NaCl) for 1 h at room temperature with shaking. The
membrane was washed and then incubated with His·Tag monoclonal antibody (Novagen),
diluted 1:3000 in 3% BSA–TBS, for 1 h at room temperature with shaking. The filter was
washed and incubated for 1 h with horseradish peroxidase-conjugated anti-mouse IgG
(Novagen) diluted 1:3000 in 10% skim milk. Immunopositive protein bands were detected
with an Enhanced Chemiluminescence Western blotting detection kit (Amersham Pharmacia
Biotech) according to the manufacturer's instructions. Prestained molecular weight standards
were obtained from New England Biolabs.
Tissue culture
Chinese hamster ovary (CHO-K1) cells were grown routinely in T25 flasks (Nunc) in Ham's
F12 medium containing 5% fetal calf serum (FCS) as described previously (Mayer et al.,
1999). Cells were detached from the plates after growth for 3–4 days by treatment with 0.5 ml
of trypsin (1 mg ml−1) in PBS for 1–3 min at 37°C and suspended in the same medium
containing 1% FCS for passage or dilution for cell assays.
CDT activity assay
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CDT activity of bacterial sonicates and spent culture medium was determined as described
previously (Mayer et al., 1999). Briefly, CHO cell suspensions were counted in a
haemocytometer and adjusted to 1 × 104 cells ml−1 medium. Twenty-four microlitres of cell
suspension and 3 ml of fresh medium were added per well in six-well plates. Bacterial sonicate
or purified recombinant protein was added to the wells at various concentrations appropriate
for each experiment. Protein was quantified with the Micro BCA protein assay kit (Pierce
Chemical). Plates were incubated for 6–7 days to allow colonies to form. The medium was
decanted, and the colonies were fixed in 10% formalin. After incubation for 5 min, the colonies
were stained with crystal violet for 10 min, the plates air dried and the colonies counted. The
number of colonies per well was expressed as colony-forming units (cfu). All samples were
run in triplicate wells.
DNase assay
DNase activity was assessed as described by Elwell and Dreyfus (2000). Supercoiled pET15b
plasmid DNA (1 μg per reaction) was incubated with various amounts of sonic extract or spent
culture medium or purified His6-tagged Cdt proteins (0–15 μg of protein per reaction) in a
buffer consisting of 25 mM HEPES (pH 7.0), 10 mM MgCl2 and 5 mM CaCl2. After a 1 h
incubation at 37°C, the reaction was stopped by the addition of 10 mM EDTA, 6% glycerol
and bromophenol blue. The samples were loaded directly on a 1% agarose gel and subjected
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to electrophoresis in TBE buffer. Gels were stained with ethidium bromide to view any changes
in the electrophoretic mobility of the supercoiled plasmid DNA band.
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Toxin reconstitution assay
The recombinant His6-tagged proteins were added either individually or in various
combinations with gentle rocking for 1 h at 4°C to CHO cells seeded in six-well plates (Costar).
Each well received 240 cells and 3.0 ml of Ham's F12 medium containing 5% FCS. Samples
containing more than one Cdt protein were premixed in various ratios as shown in the Fig. 4.
The Cdt proteins were added at the time the CHO cells were seeded on the plates. The plates
were incubated for 6 days at 37°C in an atmosphere containing 5% CO2. The medium was
removed at the end of the growth period, and 4% formalin was added to fix the colonies.
Colonies were counted after staining with crystal violet as described previously (Mayer et al.,
1999). Data are reported as colony-forming units (cfu). All samples were run in triplicate wells.
CHO cell binding assay
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CHO cells, suspended in growth medium, were added to each well (1 × 104 cells per well) of
an eight-well chamber slide (Nunc) and incubated for 48 h at 37°C in a moist atmosphere
containing 5% CO2. The medium was removed and the cells washed once with cold PBS. The
purified His6-tagged proteins were suspended in 200 μl of cold PBS and added to the wells (1–
5 μg per well). The slides were then incubated on ice for 15–30 min, washed twice with PBS
and fixed in 10% formalin for 5 min at room temperature. The slides were washed three times
with PBS, and free sites were blocked with 200 μl per well of 3% BSA in PBS for 30 min at
room temperature. The slides were washed twice with PBS and incubated with 200 μl per well
of His·Tag monoclonal antibody diluted 1:1000 in 3% BSA–PBS for 1 h at room temperature.
Unbound antibody was removed by washing the slides three times with PBS. Two hundred
microlitres of a 1:1000 dilution of Alexa Fluor 488 goat anti-mouse IgG (heavy and light chain)
conjugate (Molecular Probes) in 3% BSA–PBS was then added to each well. The slides were
washed three times, and 5 μl of mounting solution was added per well. Coverslips were placed
on the slides, which were viewed under a Nikon Eclipse E600 fluorescent microscope with a
fluorescein isothiocyanate (FITC)-HYQ filter (excitation wavelength 460–500 nm). Binding
experiments were repeated several times to confirm reproducibility.
CHO cell uptake assay
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BioPorter protein delivery reagent (Gene Therapy Systems) was dissolved in 250 μl of
chloroform. The dissolved reagent (1 μl) was added to Eppendorf tubes and dried under a hood
for 4 h at room temperature. Recombinant His6-tagged Cdt proteins were diluted in 10 mM
Tris, 150 mM NaCl (pH 7.0). Protein solutions (1 μg of protein in 50 μl of Tris buffer) were
added to the BioPorter reagent tubes and incubated for 5 min at room temperature. The samples
were then gently vortexed for 3–5 s at low speed. Serial dilutions were made, and serum-free
Ham's F12 medium was added to bring the final volume to 100 μl per well. CHO cells were
washed once and suspended in serum-free medium so that the concentration was 5000 cells
per 90 μl. This cell suspension (90 μl) was added to the BioPorter–Cdt protein mixture dilutions
and transferred to 96-well plates. The cultures were incubated for 3–4 h at 37°C; then 100 μl
of Ham's F12 medium containing 5% FCS was added to each well. The cultures were incubated
for an additional 48 h. The CellTiter96 aqueous non-radioactive cell proliferation assay kit
(Promega) was used to quantify changes in cell viability. The absorbance of each well was
measured at 492 nm. A reduction in cell viability was represented as a decrease in the A492.
All samples were run in triplicate. A standard curve of absorbance versus CHO cell number
prepared previously showed a linear increase in the A492 of a CHO cell culture over the range
of 500–5000 cells.
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Fig. 1.

SDS–PAGE of purified recombinant His6-tagged Cdt proteins. Proteins were isolated as
described in Experimental procedures, and 6 μg of each protein sample was applied to the gel.
The gel was stained with CBB. Molecular weight markers, in kDa, are shown to the left of the
gel.
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Fig. 2.

Application of anti-His monoclonal antibody for the detection of His6-tagged recombinant Cdt
proteins by Western blotting. Whole-cell lysates (25 μg of protein) from the recombinant clones
pET15bcdtA, pET15bcdtB and pET15bcdtC were applied to the gel. The blot was probed with
His•Tag monoclonal antibody at a 1:3000 dilution and horseradish peroxidase-conjugated antimouse IgG diluted 1:3000. Immunopositive bands were detected by chemiluminescence.
Molecular weight markers, in kDa, are shown to the left of the film.
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Fig. 3.

DNase activity of recombinant His6-tagged CdtB. Purified His6-tagged CdtB (0–15 μg) was
incubated for 1 h at 37°C with supercoiled plasmid DNA. The contents of the reaction tubes
were applied to a 1% agarose gel. The gel was stained with ethidium bromide. S, supercoiled
form of the plasmid DNA; R, relaxed form of the plasmid DNA.
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Fig. 4.
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In vitro reconstitution of biologically active CDT. Purified His6-tagged CdtA, His6-tagged
CdtB, His6-tagged CdtC or pairs of proteins (unshaded bars) or premixed combinations of all
three proteins (shaded bars) were added to CHO cell cultures (240 cells), and cfu were counted
after growth for 6 days. The amount of each protein, in μg, is shown on the x-axis.
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Fig. 5.

Binding of recombinant Cdt proteins to the surface of CHO cells. The proteins or combination
of proteins were incubated with CHO cells on chamber slides for 30 min at 37°C. Bound protein
was detected with His•Tag monoclonal antibody (1:1000 dilution) and fluoresceinconjugated
second antibody (1:1000 dilution). The slides were examined under a fluorescent microscope
and images recorded with a digital camera. A. His6-tagged CdtA. B. His6-tagged CdtB. C.
His6-tagged CdtC. D. Preincubated mixture of His6-tagged CdtA, His6-tagged CdtB and
His6-tagged CdtC. E. Cells incubated only with HisTag monoclonal antibody and second
antibody. F. Cells incubated only with second antibody.
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Fig. 6.
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Effect of recombinant Cdt proteins delivered to the cell cytosol. CHO cells were incubated
with the various Cdt proteins complexed with a lipid-based protein delivery reagent. A.
Increasing concentrations of His6-tagged CdtA (grey bars), His6-tagged CdtB (diagonal filled
bars) and His6-tagged CdtC (white bars) were delivered separately to CHO cells in culture.
Cultures were incubated for 48 h at 37°C. The number of surviving cells was determined
indirectly by measuring the A492 of the culture after the addition of a vital dye staining reagent.
B. Various concentrations of His6-tagged CdtA, His6-tagged CdtB, His6-tagged CdtC or
mixtures of these proteins were incubated with CHO cells using the same conditions as those
described for the experiment in (A). Proteins were added to CHO cell cultures with (white bars)
and without (diagonal filled bars) the protein delivery reagent. The numbers below the bars in
(A) and (B) represent the amount (ng) of each protein added.
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cdtA1, cdtA2
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pET15bcdtAB

pET15bcdtC

pET15bcdtB

pET15bcdtA

Construction

GCGCTCGAGAGGTACAATGA GATGGATCCTCCTTAGCG

GCGGGATCCGAATACTATGA GATGGATCCATTAGCTACCCT

GCGGGATCCAGTTTATATGCA GATGGATCCTCCTTAGCG

GCGCTCGAGAGGTACAATGA GCGGGATCCAGCTTAATT

None

PCR primers used to make construct (5' to 3')
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Plasmid

NIH-PA Author Manuscript
Table 1

His6-tagged
CdtA and
CdtB

His6-tagged
CdtC

His6-tagged
CdtB

His6-tagged
CdtA

CdtA, CdtB
and CdtC

Gene product
(s)

23,671

34,505

27,364

Calculated MW

+

−

+

−

+

−

−

−

−

DNase activity

+

Cell cycle arrest
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CDT expression clonesa.
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GCGGGATCCAGTTTATATGCA GATGGATCCATTAGCTACCCT

All plasmids were transformed into E. coli BL21(DE3).

a

1449-bp PCR
product using
primers
cdtB1', cdtC2
and DNA
from
pCRAA-14
ligated to
BamHI site of
pET15b

pET15bcdtBC
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PCR primers used to make construct (5' to 3')
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Construction

His6-tagged
CdtB and
CdtC

Gene product
(s)

Calculated MW

DNase activity

+

Cell cycle arrest

−
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